Homepage
Find out about IMI's latest funding opportunities
Cancer, tuberculosis, and psoriasis are among the topics that could be part of our next Call for proposals, IMI2 – Call 20. Also slated for inclusion in the Call are topics on drugs based on proteins, and vaccines.
In November we're looking at some of the results of our antimicrobial resistance, with a new project story every week.
In November we're looking at some of the results of our antimicrobial resistance, with a new project story every week. morePierre Meulien, Director of IMI, talks about the R&D challenges in the fight against AMR.
Pierre Meulien, Director of IMI, talks about the R&D challenges in the fight against AMR. moreEUR 27 million Immune-Image project will advance the use of imaging technologies to track immune cells.
EUR 27 million Immune-Image project will advance the use of imaging technologies to track immune cells. more
IMI BROCHURE HIGHLIGHTS PROJECT SUCCESSES
IMI projects are accelerating the medicines development process, generating new scientific insights, and developing resources for open use by the research community. Furthermore, some of our projects are already delivering direct benefits to patients. Interested in concrete numbers and examples? Find out more about the impact and outputs of our projects in our new brochure, and learn how we are 'Carrying the torch for medical innovation'.
WATCH IMI video
Carrying the torch for medical innovation
Diseases keep changing, and infections we treated for decades can once again kill. By bringing together researchers from the public and private sectors, we are working to speed up medicines development and turn knowledge into treatments. Watch our video and share it!